Related Experiment Video
Updated: Feb 24, 2026

A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
Comorbid HIV and Cocaine Use Exacerbate Accelerated Brain Aging
Hong Gu1, Betty Jo Salmeron1, Danni Wang1
1Neuroimaging Research Branch, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA.
Comorbid HIV and cocaine use accelerate brain aging, increasing cognitive impairment risk. This brain age gap highlights specific network alterations and potential intervention targets.
Area of Science:
- Neuroscience
- Neuroimaging
- Aging Research
Background:
- Human Immunodeficiency Virus (HIV) infection and cocaine use (CU) are independently associated with cognitive deficits and brain abnormalities.
- The combined impact of HIV and CU on brain aging and cognitive function remains incompletely understood.
Purpose of the Study:
- To investigate the relationship between comorbid HIV and CU and accelerated brain aging.
- To examine how the brain age gap (BAG) relates to neurocognitive impairment (NCI) in individuals with HIV and/or CU.
- To identify specific brain structural changes associated with comorbid HIV and CU.
Main Methods:
- Trained a morphometry-based brain-age model using Gaussian Process Regression on Human Connectome Project-Aging (HCP-A) data.
- Applied the model to an independent cohort with varying HIV/CU burden (HIV-/CU-, one disorder, HIV+/CU+).
- Analyzed brain age gap (BAG) in relation to comorbidity burden and NCI, controlling for covariates; used SHapley Additive exPlanation (SHAP) for network-level analysis.
Main Results:
- A dose-dependent effect of comorbidity burden on BAG was observed, with the HIV+/CU+ group exhibiting the largest BAG.
- Increased BAG was significantly associated with a higher likelihood of NCI.
- BAG partially mediated the association between comorbidity burden and NCI, with a stronger effect in the dual-disorder group.
Conclusions:
- Comorbid HIV and CU are associated with accelerated structural brain aging.
- The brain age gap may serve as a biomarker for brain alterations linking comorbid HIV/CU to cognitive impairment.
- Identifying network-specific contributions to BAG could inform targeted interventions for individuals with comorbid HIV and CU.
More Related Videos
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Drugs Affecting Neurotransmitter Synthesis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
CNS Depressants: Alcohol and Nicotine
Pharmacodynamics in Geriatric Patients: Effects of Age

